Table 1 Mitophagic failure molecular signatures in AD patient brains, fluids and cells.

From: Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches

 

Experimental approaches/methods

Molecular modifications

Expected phenotypic manifestations

Refs.

Hippocampus

Braak stage II-III

WB & RT-qPCR

↑ TOMM20 protein

↑ Mitochondrial mRNA 16S/MT-NRN2

↑ Mitochondrial mass

[12]

↑ PINK1 and PINK152 proteins

↔ Parkin protein

↓ PINK1/Parkin activation

Hippocampus & frontal cortex Braak stage V-VI

WB & RT-qPCR

↑ TOMM20 protein

↑ Mitochondrial mRNA 16S/MT-NRN2

↑ Mitochondrial mass

↔ PINK1 and PINK152 proteins

↑ Parkin protein

↓ PINK1/Parkin activation

ND

RT-qPCR

↓ PINK1 and Parkin mRNA

↓ PINK1/Parkin activation

Hippocampus & frontal cortex

Braak stage II-III & V-VI

WB

↓ Cytosolic Parkin protein

↓ PINK1/Parkin activation

[17]

ND

TEM

↑ Number of damaged mitochondria

 

WB

↑ Parkin protein

Parkin activation

↔ p62, TOMM20 and HSP60 proteins

↓ lysosomal degradation

TEM

↑ Number of mitochondria in autophagic vesicles

WB

↑ LC3-II/I protein ratio

↑ Phagophore recruitment

Hippocampus & frontal cortex

Braak stage V-VI

RT-qPCR

↓ PINK1 mRNA and protein

↓ PINK1/Parkin activation

[13]

ELISA

↑ p-S65-Ub protein

↑ Mitochondria tagged for degradation

[28]

ND

TEM

↑ Number of damaged mitochondria

 

[16]

WB

↑ pT172 AMPK protein

↓ pS555 ULK1 and pS172 TBK1 proteins

↓ Mitophagy initiation

↓ LC3-II protein

↓ Phagophores number

IHC

↓ TOMM20 – LAMP2 colocalization

↓ Mitolysosomes formation

WB

↓ DISC1 protein

↓ PINK1/Parkin-independent mitophagy

[19]

Microarray analysis

↓ NIX, BNIP3 and FUNDC1 mRNA

↓ PINK1/Parkin-dependent mitophagy

[14]

↓ OPTN, VDAC1 and VCP/p97 mRNA

↓ PINK1/Parkin-independent mitophagy

WB of Mit fraction

↓ PINK1 and Parkin protein

↓ PINK1/Parkin activation

[18]

↑ p62 protein

↓ Lysosomal degradation

↑ LC3-II/I protein ratio

↑ Phagophore recruitment

Bearers of APOEε4 allele

WB

↓ FOXO3a protein

↑ pS253 / tot FOXO3a ratio

↓ FOXO3a activity

[15]

↓ Bcl-1 and ATG12 proteins

↓ Phagosomes formation

↓ PINK1 protein

↓ p-S65-Ub protein

↓ PINK1/Parkin activation

↔ p62 protein

↓ Lysosomal degradation

Plasma

RT-qPCR

↑ PINK1 & LC3 mRNA

↓ Parkin mRNA

ND

[27]

Serum

ELISA

↓ Parkin & ATG5 proteins

ND

[26]

SAD fibroblasts

WB (Mit fraction ± CCCP

↑ TOMM20 protein

↓ Parkin protein

↑ Mitochondrial mass

↓ PINK1/Parkin activation

[12]

IF ± CCCP

↓ Parkin & SCaMC-1 colocalization

↓ Parkin recruitment to mitochondria

WB

↓ LAMP1 protein

Defective lysosomal function

MitoTimer probe

↓ Mitochondria maturation

Accumulation of dysfunctional mitochondria

[20]

WB

↓ PINK1 protein

↑ LC3-II/ I ratio

↓ PINK1/Parkin activation

↑ Phagophores number

IF & MTG probe

↔ p62 protein &

↔ mitochondrial mass

↓ Degradation

PS1 (A246E) fibroblasts

IF & WB

↑ TOMM20 protein

↑ Parkin protein

↑ Mitochondrial mass

↑ PINK1/Parkin activation

[21]

IF ± CCCP

↑ Parkin & TOMM20 colocalization

↑ Parkin recruitment to mitochondria

IF ± CCCP

↑ LC3 & TOMM20 colocalization

↑ Phagophore recruitment

LysoTracker probe ± CCCP & Baf

↓ Lysosomes acidification

↓ Lysosomal degradation

PS1 (A246E)

iPSC-differentiated neurons

IF & WB

↑ TOMM20 protein

↑ PINK1 & Parkin proteins

↑ Mitochondrial mass

↑ PINK1/Parkin activation

 

IF ± CCCP

↑ Parkin & TOMM20 colocalization

↑ Parkin recruitment to mitochondria

 

WB

↓ Pro-cathepsin B activation

↓ Lysosomal degradation

 

APP (V717L) & APOEε4/ε4

iPSC-differentiated neurons

WB

↓ Bcl-1 protein & pS555 ULK1 and pS172 TBK1 proteins

↓ PINK1 protein

↓ AMBRA1, BCL2L13 & FUNDC1 proteins

↓ Mitophagy initiation

↓ PINK1/Parkin initiation

↓ PINK1/Parkin-independent mitophagy activation

[16]

KI PS1 (M146L)

iPSC-differentiated neural stem cells

WB ± CCCP

↑ TOMM20 protein

↑ PINK1 & Parkin proteins

↑ Mitochondrial mass

↑ PINK1/Parkin activation

[24]

IF ± CCCP

↑ PINK1 & Parkin proteins

↑ Parkin & TOMM20 colocalization

Parkin recruitment to mitochondria

↓ Phagophore recruitment

RT-qPCR and WB

↓ LC3 & TOMM20 colocalization

↓ TFEB & LAMP1 mRNA & proteins

↓ Lysosomal degradation

Neuronal cybrids

WB

↓ PINK1 protein

↓ PINK1/Parkin activation

[25]

  1. Phenotype modifications and/or levels of mRNA or proteins are depicted as ↑ (increased), ↓ (decreased), or ↔ (unchanged) as compared to control individual (brain samples, blood, serum and cells). ND Not determined, iPSC Induced pluripotent stem cells, iNSC Induced neural stem cells, FAD Familial Alzheimer’s disease, SAD Sporadic Alzheimer’s disease, PS1/2 Presenilin 1/2, KI Knock in, WB Western blot, TEM Transmission electron microscopy, IHC Immunohistochemistry, IF Immunofluorescence, Baf Bafilomycin, CCCP Carbonyl cyanide m-chlorophenylhydrazone, Mit fraction Mitochondrial fraction, MTG Mitotracker green probe.